Verve Therapeutics Statistics
Total Valuation
HKHGF has a market cap or net worth of 13.15 billion. The enterprise value is 18.11 billion.
Market Cap | 13.15B |
Enterprise Value | 18.11B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | Mar 20, 2025 |
Share Statistics
Current Share Class | 2.18B |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.22% |
Shares Change (QoQ) | -0.12% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 998.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 20.04 |
PS Ratio | 7.38 |
PB Ratio | 0.44 |
P/TBV Ratio | 0.44 |
P/FCF Ratio | 25.47 |
P/OCF Ratio | 21.26 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.51, with an EV/FCF ratio of 35.07.
EV / Earnings | -54.71 |
EV / Sales | 10.17 |
EV / EBITDA | 14.51 |
EV / EBIT | 14.67 |
EV / FCF | 35.07 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.20.
Current Ratio | 1.74 |
Quick Ratio | 0.61 |
Debt / Equity | 0.20 |
Debt / EBITDA | 7.19 |
Debt / FCF | 11.68 |
Interest Coverage | 3.87 |
Financial Efficiency
Return on equity (ROE) is -1.08% and return on invested capital (ROIC) is 1.42%.
Return on Equity (ROE) | -1.08% |
Return on Assets (ROA) | 1.33% |
Return on Invested Capital (ROIC) | 1.42% |
Return on Capital Employed (ROCE) | 2.28% |
Revenue Per Employee | 581,423 |
Profits Per Employee | -108,064 |
Employee Count | 3,063 |
Asset Turnover | 0.05 |
Inventory Turnover | 0.35 |
Taxes
In the past 12 months, HKHGF has paid 131.90 million in taxes.
Income Tax | 131.90M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.27% in the last 52 weeks. The beta is 0.24, so HKHGF's price volatility has been lower than the market average.
Beta (5Y) | 0.24 |
52-Week Price Change | +70.27% |
50-Day Moving Average | 4.46 |
200-Day Moving Average | 4.40 |
Relative Strength Index (RSI) | 68.89 |
Average Volume (20 Days) | 13,954 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKHGF had revenue of 1.78 billion and -331.00 million in losses. Loss per share was -0.15.
Revenue | 1.78B |
Gross Profit | 976.50M |
Operating Income | 825.60M |
Pretax Income | -194.00M |
Net Income | -331.00M |
EBITDA | 836.60M |
EBIT | 825.60M |
Loss Per Share | -0.15 |
Balance Sheet
The company has 1.11 billion in cash and 6.03 billion in debt, giving a net cash position of -4.92 billion.
Cash & Cash Equivalents | 1.11B |
Total Debt | 6.03B |
Net Cash | -4.92B |
Net Cash Per Share | n/a |
Equity (Book Value) | 29.76B |
Book Value Per Share | 13.51 |
Working Capital | 1.81B |
Cash Flow
In the last 12 months, operating cash flow was 618.70 million and capital expenditures -102.40 million, giving a free cash flow of 516.30 million.
Operating Cash Flow | 618.70M |
Capital Expenditures | -102.40M |
Free Cash Flow | 516.30M |
FCF Per Share | n/a |
Margins
Gross margin is 54.83%, with operating and profit margins of 46.36% and -18.59%.
Gross Margin | 54.83% |
Operating Margin | 46.36% |
Pretax Margin | -10.89% |
Profit Margin | -18.59% |
EBITDA Margin | 46.98% |
EBIT Margin | 46.36% |
FCF Margin | 28.99% |
Dividends & Yields
This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 3.67%.
Dividend Per Share | 0.23 |
Dividend Yield | 3.67% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.22% |
Shareholder Yield | 3.88% |
Earnings Yield | -2.52% |
FCF Yield | 3.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKHGF has an Altman Z-Score of 1.9 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.9 |
Piotroski F-Score | 6 |